The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Davide Capodanno succeeds Patrick W. Serruys as Editor-in-Chief of EuroIntervention

A new Editor-in-Chief for EuroIntervention, the official journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions

EuroIntervention is pleased to announce that Professor Davide Capodanno will be taking over the role of Editor-in-Chief, effective January 1st, 2020.

Since founding the Journal in May 2005, Professor Patrick W. Serruys has devoted a large part of his life to EuroIntervention’s expansion along with its respected reputation amongst the top journals in the field.

We would like to warmly thank Professor Serruys for his commitment and outstanding contribution over the last 15 years.

I thank PCR and EAPCI for their trust. I pick up a heavy legacy; if EuroIntervention has become a reference for the interventional community we owe it to the substantial work of Patrick W. Serruys. When the mark of those that come before you is so indelible, the worst mistake you could make is to imitate. For this reason, the Editorial Team will introduce new features to lead the Journal in the new decade. These will complement the assets that have made EuroIntervention so successful: innovation, technique, practice and academia. We must center our efforts on the experience of readers, authors, reviewers and all those who in various way deal with the Journal”. Davide Capodanno

Davide Capodanno, MD, PhD, is Associate Professor of Cardiology at the University of Catania and Interventional Cardiologist at the Cardiac-Thoracic-Vascular Department, Azienda “Policlinico-Vittorio Emanuele” in Catania, Italy. He received his MD and PhD from the University of Catania and completed his research training at the University of Florida in Jacksonville, USA.

The recipient of multiple Investigator Awards for cardiology research, Assoc. Prof. Capodanno has authored around 450 manuscripts published in the peer-reviewed literature, including original articles, reviews and editorials. He has delivered more than 200 invited lectures in international meetings, including ESC, ACC, EuroPCR, TCT, CIT, TCTAP. Dr Capodanno’s areas of interest and expertise include antithrombotic pharmacotherapy, coronary revascularization, trial design and biostatistics.

Prof. Capodanno is the Chair of the Scientific Documents and Initiatives Committee of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). He is Co-Director of the PCR Clinical Research Course and Associate Director of TCT. He is a member of the Working Group on Thrombosis of the ESC and a member of the Educative Solutions Research Group Programme of PCR. Dr. Capodanno is current Associate Editor of the European Heart Journal and served as Editor-in-Chief of and Deputy Editor of EuroIntervention.